Gregory M Weinhoff is Chief Business Officer of Centessa Pharmaceuticals plc. Currently has a direct ownership of 183,266 shares of CNTA, which is worth approximately $3.11 Million. The most recent transaction as insider was on Dec 26, 2024, when has been sold 10,000 shares (Ordinary Shares) at a price of $17.04 per share, resulting in proceeds of $170,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 183K
11.36% 3M change
31.83% 12M change
Total Value Held $3.11 Million

Gregory M Weinhoff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 26 2024
SELL
Open market or private sale
$170,400 $17.04 p/Share
10,000 Reduced 5.17%
183,266 Ordinary Shares
Dec 26 2024
BUY
Exercise of conversion of derivative security
$38,500 $3.85 p/Share
10,000 Added 4.92%
193,266 Ordinary Shares
Nov 25 2024
SELL
Open market or private sale
$176,600 $17.66 p/Share
10,000 Reduced 5.17%
183,266 Ordinary Shares
Nov 25 2024
BUY
Exercise of conversion of derivative security
$38,500 $3.85 p/Share
10,000 Added 4.92%
193,266 Ordinary Shares
Oct 25 2024
SELL
Open market or private sale
$180,591 $15.38 p/Share
11,742 Reduced 6.02%
183,266 Ordinary Shares
Sep 30 2024
SELL
Payment of exercise price or tax liability
$185,406 $15.79 p/Share
11,742 Reduced 5.68%
195,008 Ordinary Shares
Sep 25 2024
SELL
Open market or private sale
$260,752 $15.69 p/Share
16,619 Reduced 7.44%
206,750 Ordinary Shares
Sep 10 2024
SELL
Open market or private sale
$510,000 $17.0 p/Share
30,000 Reduced 11.84%
223,369 Ordinary Shares
Sep 10 2024
BUY
Exercise of conversion of derivative security
$175,200 $5.84 p/Share
30,000 Added 10.59%
253,369 Ordinary Shares
Sep 09 2024
SELL
Open market or private sale
$375,000 $15.0 p/Share
25,000 Reduced 10.07%
223,369 Ordinary Shares
Sep 09 2024
BUY
Exercise of conversion of derivative security
$146,000 $5.84 p/Share
25,000 Added 9.15%
248,369 Ordinary Shares
Aug 23 2024
SELL
Open market or private sale
$218,786 $12.29 p/Share
17,802 Reduced 7.38%
223,369 Ordinary Shares
Aug 22 2024
SELL
Open market or private sale
$148,449 $12.17 p/Share
12,198 Reduced 4.81%
241,171 Ordinary Shares
Jun 30 2024
SELL
Payment of exercise price or tax liability
$106,030 $9.03 p/Share
11,742 Reduced 4.43%
253,369 Ordinary Shares
Mar 31 2024
SELL
Payment of exercise price or tax liability
$132,684 $11.3 p/Share
11,742 Reduced 4.24%
265,111 Ordinary Shares
Feb 01 2024
SELL
Payment of exercise price or tax liability
$94,135 $8.19 p/Share
11,494 Reduced 3.99%
276,853 Ordinary Shares
Feb 01 2024
BUY
Grant, award, or other acquisition
-
31,250 Added 9.78%
288,347 Ordinary Shares
Dec 31 2023
SELL
Payment of exercise price or tax liability
$93,466 $7.96 p/Share
11,742 Reduced 4.37%
257,097 Ordinary Shares
Sep 30 2023
SELL
Payment of exercise price or tax liability
$75,970 $6.47 p/Share
11,742 Reduced 4.18%
268,839 Ordinary Shares
Jun 30 2023
SELL
Payment of exercise price or tax liability
$69,277 $5.9 p/Share
11,742 Reduced 4.02%
280,581 Ordinary Shares
Mar 31 2023
SELL
Payment of exercise price or tax liability
$32,338 $3.9 p/Share
8,292 Reduced 2.76%
292,323 Ordinary Shares
Feb 01 2023
BUY
Grant, award, or other acquisition
-
77,200 Added 20.43%
300,615 Ordinary Shares
Dec 31 2022
SELL
Payment of exercise price or tax liability
$16,439 $3.1 p/Share
5,303 Reduced 2.21%
234,697 Ordinary Shares
Oct 03 2022
SELL
Open market or private sale
$19,359 $3.95 p/Share
4,901 Reduced 2.08%
231,099 Ordinary Shares
Sep 30 2022
SELL
Payment of exercise price or tax liability
$47,948 $4.25 p/Share
11,282 Reduced 4.7%
228,718 Ordinary Shares
GMW

Gregory M Weinhoff

Chief Business Officer
Cheshire, X0

Track Institutional and Insider Activities on CNTA

Follow Centessa Pharmaceuticals plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA